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Table S6. Infection related gene changes and ingenuity canonical pathways in human islets
The ratio is calculated that the number of molecules in a given pathway that meet cutoff |1.5|, divided by total number of molecules that make up that pathway that are in the reference set. Bold type indicates increased gene expression in non-infected vs. Ad-RIP-Ctrl comparisons.
Ingenuity Canonical Pathways p-value Ratio Molecules
Agranulocyte Adhesion and Diapedesis 1.70E-05 1.49E-01 CLDN11,SELE,MMP3,CCL22,MMP25,CXCL9, CLDN6,MYH7  B,CXCL6,MYL7,CXCL10,CXCL3,IL18,CLDN5,CCL21,MYH  3,CXCL1,CXCL17,ACTA1,MMP9 ,CLDN3 Granulocyte Adhesion and Diapedesis 3.39E-04 1.31E-01 CLDN11,SELE,MMP3,CCL22,CSF3,MMP25,CXCL9,CLDN6, C  XCL6,CXCL10,CXCL3,IL18,CLDN5,CCL21,CXCL1,CXCL17 
